A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to help the ...

First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

MicroPort CardioFlow Medtech Corp. ( ($HK:2160) ) just unveiled an update. MicroPort CardioFlow Medtech Corporation announced the formal release ...

Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the ...

After previously backing the startup, Edwards Lifesciences is exercising its option to acquire Innovalve and its mitral valve replacement implant. In an SEC filing, Edwards said it plans to pay about ...

Symptoms of mitral valve prolapse may cause or increase anxiety for some people. Stress and anxiety may contribute to the development of heart problems but aren’t a common cause of mitral valve ...

Mitral valve prolapse is a structural change in the mitral valve of the heart. Rather than closing tightly, one or both flaps of the valve billow into the left atrium of the heart. People sometimes ...